Abridge raises $300 million at $5.3 billion valuation
Abridge scaled its AI clinical intelligence layer that converts patient-clinician conversations into ambient documentation, real-time prior authorization, and clinical decision support. Founded in 2018, the company has processed over 100 million medical conversations. It now projects coverage for more than 80 million visits across 250 U.S. health systems in 28 languages and 50 specialties. In June 2025 Abridge raised $300 million at a $5.3 billion valuation after a $250 million round earlier that year.
#214swyx 🇸🇬 AIE Singapore!@SWYXbeing vulnerable - by far one of the most important applied ai fields is in AI x Healthcare, but nobody on my team knows how to cover it!
very fortunate to have @jacobeffron on the pod for this one - I took a healthcare economics class once many moons ago, but not only is he on the @AbridgeHQ board, he’s also an excellent podcaster (@ULpodcast) in his own right and people really enjoyed our annual crossover pod chat. I organically bring up a lot of @redpoint portcos in many of my conversations and his questions here were very on point if you are interested in how AI is improving healthcare outcomes and finances across the board!
Latent.Space@latentspacepodAbridge: 100M+ medical conversations, real-time prior auth, and the clinical intelligence layer https://www.latent.space/p/abridge @AbridgeHQ is building the clinical intelligence layer for healthcare. In this episode, Janie Lee and @c_asawa explain why ambient documentation was only the first wedge, how Abridge is turning patient conversations into real-time clinical decision support, why healthcare may become one of AI’s most important proving grounds, and how 100M+ medical conversations, specialty-specific evals, and deep EHR integrations create a moat for AI-native healthcare.